PFAS Research and Development Reauthorization Act of 2025
Summary
HB6667, the PFAS Research and Development Reauthorization Act of 2025, would extend the existing federal authorization for Environmental Protection Agency appropriations related to PFAS research and development. The bill is narrowly drafted: it amends section 7362(b) of the National Defense Authorization Act for Fiscal Year 2020 by replacing the sunset year “2024” with “2030,” thereby continuing the authority for funding EPA work on PFAS for an additional six years.
PFAS are a class of persistent synthetic chemicals often referred to as “forever chemicals” because they do not readily break down in the environment and have been linked to contamination of drinking water, soil, and other resources. By extending the authorization, the bill would support continued federal research into detection, health effects, remediation, and other PFAS-related issues, with potential downstream effects for environmental regulators, water systems, public health agencies, and communities affected by contamination.
Impact
The bill would amend federal law only in a limited way by changing the authorization period in 15 U.S.C. 8962(b) from 2024 to 2030. It does not itself create new regulatory standards or mandates, but it would preserve the legal basis for EPA appropriations devoted to PFAS research and development, allowing continued federal spending and study in this area. The practical effect would be to sustain federal support for scientific and technical work on PFAS contamination and cleanup.
Sentiment
The available context suggests the bill is generally favorable and noncontroversial in concept, as it is a straightforward reauthorization of an existing PFAS research program. There are no recorded committee transcripts or votes in the provided material, and the bill was referred to the Subcommittee on Water Resources and Environment. The absence of recorded opposition in the provided context, combined with the bill’s limited and technical nature, indicates a generally supportive posture toward continuing PFAS research funding.
Contention
No specific points of contention are documented in the provided materials. In similar PFAS legislation, potential areas of debate can include the scope of EPA authority, the level and duration of federal funding, and whether Congress should pair research funding with broader PFAS regulation or cleanup requirements. However, none of those disputes are reflected in the text, votes, or transcripts supplied here.